The research group led by CIC biomaGUNE’s Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative anti-fibrotic and anti-tumor treatment by binding a synthetic protein to gold nanoclusters (small aggregates of approximately 6 atoms of gold). Conducted in collaboration with the group led by Dr. Ana Beloqui at the Catholic University of Louvain (Belgium), the study, published in Bioactive Materials, has demonstrated that this hybrid formulation displays strong hepatic specificity and minimal side effects in mice.
Continue Reading this article here
